Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor

Sarah Snykers and Dr. Jose Castillo, Pall Life Sciences joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to discuss ‘Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor.’ Download this presentation now to find out: Promethera® Biosciences • Who we are? • Our process & product …

Can cell therapy become the next generation of biological therapeutic products?

Zami Aberman, Chairman and Chief Executive Officer, Pluristem joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present ‘Can cell therapy become the next generation of biological therapeutic product?’ Download this presentation now to find out: Can cell therapy become the next generation of biological therapeutic products? Cell therapy “must haves” to become the next biological …

The Stem Cells Regenerative Medicine Congress is where experts like Fisher BioServices gather to network, learn from each other, and discuss the latest stem cell developments.

Fisher BioServices Publishes eBook on Commercially Successful Cell Therapies

If you have a cell-based therapy in development, then you need to consider such variables as packaging, storage, inventory management, monitoring systems, distribution, and even clinical site capabilities well before you begin to prepare the Investigational New Drug (IND) submission to the Food and Drug Administration (FDA). By sidestepping these issues until clinical trials begin, you may discover late in …

Stem Cells USA is where solution providers like Fisher Bioservices gather to network, present their products and solutions, and meet with their target audiences

Delivering Your Cell Therapy: Getting Reliable Performance from Dry Shippers

The above video and following article were provided by Fisher BioServices, an Associate Sponsor of the Stem Cells Regenerative Medicine Congress 2014. This content was originally posted by  Dan O’Donnell on May 1, 2014. A cell therapy clinical trial can fail for any number of reasons many of which are unavoidable. Many of these failures can be avoided by understanding the basic …

Download Manufacturing Flexibility – Understanding scale up for your Cell Therapy

Richard Grant, Invetech joined us last year at the World Stem Cells & Regenerative Medicine Congress to present on ‘Manufacturing Flexibility – Understanding scale up for your Cell Therapy.’ Download this presentation now to find out more about: Commercialisation of a Cell Therapy is all about balance. Is your current process under control and scalable? What are the priorities for …

Cell Culture World Congress USA is where the best in cell therapy and manufacturing come together with solution providers to network and discuss the latest cell developments and technologies.

Rapid Microbiological Methods in Autologous Cell Therapy

John Duguid, Principal Process/Analytical Scientist of Manufacturing Technical Services at Genzyme, presented at Cell Culture World Congress USA 2013. An attentive audience listened to him as he addressed rapid Microbiological Methods in autologous cell therapy. Download his presentation now > You can now watch the video of his presentation and view his slides, which discuss: Challenges associated with testing autologous …

Video: John Duguid of Genzyme on rapid microbiological methods in cell therapy

John Duguid, Principal Process/Analytical Scientist, Manufacturing Technical Services at Genzyme, speaks on ‘Rapid Microbiological Methods in autologous cell therapy: advantages, limitations, support and obstacles.’ If you liked this video then why not have a look at our other videos from Cell Culture World Congress USA 2013. Cell Culture World Congress USA is North America’s premier cell culture optimization and development …

Video: Highlights from North America’s leading Stem Cell, Cord Blood and Cell Culture events

In September 2013 stem cells, cord blood and cell culture industry executives gathered in Cambridge, MA to network and share insights in these unique but related sectors. Check out the event highlights above. Stem Cells & Regenerative Medicine Congress is where biotechs gather to explore the most promising trends in stem cell, cell and gene therapies. World Cord Blood Congress …

Increasing struggles in cell therapies manufacturing as production ramps up

Even though there has been an increasing number of cell therapies advancing to late-stage clinical development, several aspects of cell therapy development continue to present considerable challenges for large scale commercialization. It is clear that production of biologics in general carries higher risks than of small molecules pharmaceuticals and this becomes even more evident as production of cell therapies ramps …

Discover how to successfully scale-up Stem Cell manufacturing

At this year’s World Stem Cells & Regenerative Medicine Congress in London from 21-23 May, the 9.10am Keynote Presentation from ATMI Lifesciences on Day 3 will show you ‘How to driver overall costs of goods down with the right process in place’. The talk will be delivered by Jose Castillo, Director of Cell Culture Technologies at ATMI Lifesciences in conjunction …